Tumorad is a nanomaterial which is linked to radioactive isotopes, in order to radiate tumors in a tumors in a targeted manner. These isotopes can be adjusted so as to chose the optimal radiation type, reach, and half-life. With an optimal half-life, there’s enough time to combat tumours without destroying healthy cells. The technique uses the EPR effect (Enhanced Permeability and Retention). A phenomena that is seen often in tumours and was first described in 1986. The EPR effect is based on the drainage of nano material by the lymph vessels in healthy cells. Tumour cells experience a lack of lymphatic drainage, which allows the material to accumulate. This way, the radioactive substance has time to break down targeted cells. This way, a concentrated dose of the right medication can be delivered, without severe side-effects.
